Skip to main content

X4 Pharmaceuticals, Inc insider trading

XFORNASDAQ
$2.77-0.13 (-4.48% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 6, 2026. Price (-17.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Unlock quarterly net flow

Key players

  • ARAdam R. CraigExecutive Chairman0.3315%of company
  • JVJohn VolponePresident0.2676%of company
  • DKDavid KirskeChief Financial Officer0.1573%of company
  • PRPaula RaganPresident and CEO0.1122%of company
  • MDMary DiBiaseChief Operating Officer0.0384%of company
  • CAChristophe Arbet-EngelsChief Medical Officer0.0291%of company
  • ASAdam S. MostafaChief Financial Officer0.0286%of company
  • MBMark BaldryChief Commercial Officer0.0256%of company
  • ATArthur TaverasChief Scientific Officer0.013%of company
  • NFNatasha Fay ThorenChief Legal Officer0.0095%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
XFORDavid KirskeChief Financial OfficerOpen market sell$33.7K-7.0%$2.86$33.7KOct 1, 2026Oct 5, 2026
XFORJohn VolponePresidentOpen market sell$109K-8.5%$4.44$109KAug 12, 2026Aug 13, 2026
XFORAdam R. CraigExecutive ChairmanOpen market sell$211K-12.6%$4.44$211KAug 12, 2026Aug 13, 2026
XFORDavid KirskeChief Financial OfficerOpen market sell$36.4K-4.9%$4.26$36.4KJun 30, 2026Jul 1, 2026
XFORDavid KirskeChief Financial OfficerOpen market sell$72.8K-8.8%$4.29$72.8KMay 12, 2026May 13, 2026
XFORAdam R. CraigExecutive ChairmanOpen market purchase$250K+29.7%$2.90$250KOct 23, 2025Oct 27, 2025
End of history · 6 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.